DEVICE RAC Exam Questions / Comprehensive Study
Guide – Expert Strategies, Review of Key Quizzes, and
Practice Questions for Guaranteed Success
Which division would have primary jurisdiction over a vascular graft with an
antibiotic based on primary mode of action?
A. CDER
B. CBER
C. CDRH
D. OCP - (ANSWER)C
A company wants to modify its legally marketed device such that the modification
does not affect the intended use or alter the fundamental scientific technology of
the device. If the design outputs of the modified device meet the design input
requirements, this change would be best filed as a(n):
A. Special 510(k)
B. Abbreviated 510(k)
C. Traditional 510(k)
D. De novo 510(k) - (ANSWER)A
Under the statutory violations, failure to meet 510(k) requirements for a device
that is required to have a 510(k) and is in commercial distribution is considered to
be:
A. Adulteration.
B. Improper use
,C. Misbranded
D. Fraudulent - (ANSWER)C
A company's competitor is marketing a Class II suture which dissolves during the
third week of use. The company's current product has to be removed by a
physician. However, a change in weaving configuration gives this product the
same dissolving time as the competitor's. When can the company's new suture be
marketed?
A. This requires a new 510(k) since significant change in product instructions
might
affect efficacy.
B. After submission in a periodic report
C. After reporting clinical studies in an annual report
D. After submission of labeling change - (ANSWER)A
Which of the following is exempt from GMP/QSR regulations?
A. Remanufacturers
B. Custom device manufacturers
C. Repackagers
D. Component manufacturers - (ANSWER)D
A physician reports to a manufacturer that a patient was hospitalized with acute
sepsis after treatment with an approved device. This side effect is not listed in the
, package insert. This event must be reported by the manufacturer to FDA no later
than:
A. 5 calendar days
B. 15 calendar days
C. 30 calendar days
D. The next quarterly or annual report - (ANSWER)C
If a device failure is occurring with greater than expected frequency and
investigation of the problem implicates improper use by the end user, which of
the following typically occurs?
A. The labeling is revised.
B. The product is recalled.
C. The product is redesigned.
D. A "Dear Doctor" letter is issued. - (ANSWER)A
A handling and storage system for medical devices must always include:
A. Procedures for rotation of stock
B. Separate rooms or cages for release and quarantine products
C. Procedures for receipt and transfer of product
D. Environmentally controlled areas for products with shelf life - (ANSWER)C
You have modified your 510(k) cleared device with a special 510(k). In which of
the following cases would you need to create a new listing for the device?
Guide – Expert Strategies, Review of Key Quizzes, and
Practice Questions for Guaranteed Success
Which division would have primary jurisdiction over a vascular graft with an
antibiotic based on primary mode of action?
A. CDER
B. CBER
C. CDRH
D. OCP - (ANSWER)C
A company wants to modify its legally marketed device such that the modification
does not affect the intended use or alter the fundamental scientific technology of
the device. If the design outputs of the modified device meet the design input
requirements, this change would be best filed as a(n):
A. Special 510(k)
B. Abbreviated 510(k)
C. Traditional 510(k)
D. De novo 510(k) - (ANSWER)A
Under the statutory violations, failure to meet 510(k) requirements for a device
that is required to have a 510(k) and is in commercial distribution is considered to
be:
A. Adulteration.
B. Improper use
,C. Misbranded
D. Fraudulent - (ANSWER)C
A company's competitor is marketing a Class II suture which dissolves during the
third week of use. The company's current product has to be removed by a
physician. However, a change in weaving configuration gives this product the
same dissolving time as the competitor's. When can the company's new suture be
marketed?
A. This requires a new 510(k) since significant change in product instructions
might
affect efficacy.
B. After submission in a periodic report
C. After reporting clinical studies in an annual report
D. After submission of labeling change - (ANSWER)A
Which of the following is exempt from GMP/QSR regulations?
A. Remanufacturers
B. Custom device manufacturers
C. Repackagers
D. Component manufacturers - (ANSWER)D
A physician reports to a manufacturer that a patient was hospitalized with acute
sepsis after treatment with an approved device. This side effect is not listed in the
, package insert. This event must be reported by the manufacturer to FDA no later
than:
A. 5 calendar days
B. 15 calendar days
C. 30 calendar days
D. The next quarterly or annual report - (ANSWER)C
If a device failure is occurring with greater than expected frequency and
investigation of the problem implicates improper use by the end user, which of
the following typically occurs?
A. The labeling is revised.
B. The product is recalled.
C. The product is redesigned.
D. A "Dear Doctor" letter is issued. - (ANSWER)A
A handling and storage system for medical devices must always include:
A. Procedures for rotation of stock
B. Separate rooms or cages for release and quarantine products
C. Procedures for receipt and transfer of product
D. Environmentally controlled areas for products with shelf life - (ANSWER)C
You have modified your 510(k) cleared device with a special 510(k). In which of
the following cases would you need to create a new listing for the device?
